Figure 4

WEE1 as a therapeutic target for uveal melanoma. (a) The results of kinome-wide siRNA screening to identify therapeutic targets for uveal melanoma. (b) The cell viability of multiple cancer cells treated with the WEE1 inhibitor (MK-1775) at the indicated doses.